Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy Study of Sodium Channel Blocker in LQT3 Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by University of Rochester
Gilead Sciences
Information provided by (Responsible Party):
Wojciech Zareba, University of Rochester Identifier:
First received: July 18, 2012
Last updated: September 28, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)